Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Hexamethylene bisacetamide inhibits BET Bromodomain Proteins.
パッケージサイズ | 在庫状況 | 単価(税別) | |||
---|---|---|---|---|---|
サンプルについてお問い合わせ | |||||
25 mg | 在庫あり | ¥ 10,000 | |||
50 mg | 在庫あり | ¥ 15,500 | |||
100 mg | 在庫あり | ¥ 21,000 | |||
1 mL * 10 mM (in DMSO) | 在庫あり | ¥ 10,500 |
説明 | Hexamethylene bisacetamide inhibits BET Bromodomain Proteins. |
In vitro | As expected of a BET inhibitor, HMBA displaced BET proteins from chromatin, caused massive transcriptional changes, and triggered cell-cycle arrest and apoptosis in Myc-induced B-cell lymphoma cells.?Furthermore, HMBA exerted anticancer effects in vivo in mouse models of Myc-driven B-cell lymphoma[1]. |
分子量 | 200.28 |
分子式 | C10H20N2O2 |
CAS No. | 3073-59-4 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 25 mg/mL (124.82 mM)
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Hexamethylene bisacetamide 3073-59-4 Chromatin/Epigenetic Epigenetic Reader Domain Inhibitor HMBA inhibit inhibitor